Australia markets close in 7 minutes

TOT BIOPHARM International Company Limited (1875.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
2.510-0.070 (-2.71%)
As of 01:00PM HKT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
780,629
780,629
442,178
76,325
22,491
-
Cost of revenue
206,643
206,643
71,563
48,851
6,961
-
Gross profit
573,986
573,986
370,615
27,474
15,530
-
Operating expenses
Research development
103,890
103,890
151,168
214,699
235,196
-
Selling general and administrative
509,329
509,329
266,541
79,185
72,808
-
Total operating expenses
595,433
595,433
409,449
282,928
305,268
-
Operating income or loss
-21,447
-21,447
-38,834
-255,454
-289,738
-
Interest expense
5,175
5,175
6,602
2,468
1,706
-
Income before tax
-37,756
-37,756
-50,046
-261,216
-288,498
-
Income tax expense
1
1
0
0
0
-
Income from continuing operations
-37,757
-37,757
-50,046
-261,216
-288,498
-
Net income
-37,757
-37,757
-49,916
-261,216
-288,498
-
Net income available to common shareholders
-37,757
-37,757
-49,916
-261,216
-288,498
-
Basic EPS
-0.07
-
-0.08
-0.46
-0.51
-0.89
Diluted EPS
-0.07
-
-0.08
-0.46
-0.51
-0.89
Basic average shares
714,307
-
639,307
573,360
570,334
335,654
Diluted average shares
714,307
-
639,307
573,360
570,334
335,654